FIGURE 1.

Overview of the validation methodology proposed by the applicant in support of their fit‐for‐purpose dermal physiologically‐based pharmacokinetic models for Voltaren topical gel, 1% (reference, R) and for the generic diclofenac sodium topical gel, 1% (test, T)